Tag: Prescription Drugs

Patients of African ancestry had the lowest precision oncology drug-based clinical actionability from 2019 onward

Decrease in mortality, morbidity seen with trametinib for children with RASopathy-associated hypertrophic cardiomyopathy

Polypill treatment estimated at $8,560 per QALY gained compared with usual care and had high value in 99 percent of simulations

Significantly lower protein levels seen with SSRIs and steroids; mean fat lower for mothers with other anti-inflammatory drugs

Grade 3 or 4 adverse events occurred in 96 percent of patients; grade 3 or 4 infections occurred in 64 percent

Findings seen within a single health care system during the early period of availability

Denosumab has greater preventive effect on fractures, but increased risk for MACE compared with oral bisphosphonates

Findings seen in older adults with diabetic neuropathy, postherpetic neuralgia, or fibromyalgia

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol

Odds of complications significantly reduced with early anti-TNFα therapy, especially in those with perianal lesions